Crossmark

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1038/s41598-024-74712-x

Published Online: 2024-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Einarsdottir, Sigrun

Al-Dury, Samer

Fridriksson, Ellen

Andius, Linn Dahlsten

Wang, Hao

Sharba, Sinan

Mountagui, Amin

Waern, Johan

Ringlander, Johan

Martner, Anna

Hellstrand, Kristoffer

Waldenström, Jesper

Lagging, Martin
Funding

Funding for this research was provided by:

University of Gothenburg
License Information

Text and Data Mining valid from 2024-10-21

Version of Record valid from 2024-10-21
More Information

Article History

Received: 28 May 2024

Accepted: 27 September 2024

First Online: 21 October 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below